“
EyePoint, Inc.
ManojNair · March 4, 2026
EyePoint, Inc. (NASDAQ: EYPT), which is engaged within the growth of therapeutics for retinal illnesses, on Wednesday introduced monetary outcomes for the fourth quarter of fiscal 2025, reporting decrease revenues and a wider net loss.
Source link
#Earnings #Abstract #EyePoint #EYPT #net #loss #widens #AlphaStreet #News
